NKGen Biotech, Inc.
NKGN
$0.1151
-$0.0146-11.26%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.01M | 4.37M | 4.39M | 5.34M | 2.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.79M | 7.46M | 7.62M | 9.43M | 6.90M |
| Operating Income | -6.79M | -7.46M | -7.62M | -9.43M | -6.90M |
| Income Before Tax | 6.60M | -16.09M | -5.38M | -33.60M | -33.18M |
| Income Tax Expenses | -- | -- | -- | 7.00K | -- |
| Earnings from Continuing Operations | 6.60M | -16.09M | -5.38M | -33.61M | -33.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.60M | -16.09M | -5.38M | -33.61M | -33.18M |
| EBIT | -6.79M | -7.46M | -7.62M | -9.43M | -6.90M |
| EBITDA | -6.49M | -7.16M | -7.33M | -9.13M | -6.60M |
| EPS Basic | 0.23 | -0.67 | -0.25 | -1.55 | -2.48 |
| Normalized Basic EPS | -0.22 | -0.68 | -0.14 | -0.97 | -1.47 |
| EPS Diluted | 0.15 | -0.67 | -0.25 | -1.55 | -2.48 |
| Normalized Diluted EPS | -0.16 | -0.68 | -0.14 | -0.97 | -1.47 |
| Average Basic Shares Outstanding | 29.13M | 24.17M | 21.94M | 21.68M | 13.40M |
| Average Diluted Shares Outstanding | 41.33M | 24.17M | 21.94M | 21.68M | 13.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
